BILL • US HOUSE
HR 1843 boosts transparency in generic drug applications, ensuring clearer info on equivalence for manufacturers, improving access to reliable, affordable medications for consumers.
No documents available
Referred to the House Committee on Energy and Commerce.
Introduced in House
No votes available
We're glad to see you!
New to WeVote? Claim your Voter Profile now!
Are you an elected rep? Claim account
Join thousands of verified voters to weigh in.
Already have an account? Log in
Are you an elected rep? Claim account
No worries! Enter your email and we'll send you reset instructions.
Remember your password? Back to Login
Your email address has not been confirmed yet. Please check your inbox or request a new confirmation link below.
Didn't receive the email?
Already confirmed? Back to Login
You need to take action to continue.
You're currently in
Joining this room will disconnect you from the current one.
The meeting has ended.
